## Abstract In order to differentiate Epstein‐Barr virus (EBV) strains by serological markers we prepared hybridomas producing monoclonal antibodies against polypeptides of the QIMR‐WIL EBV strain. These monoclonal antibodies were screened by indirect immunofluorescence techniques. Immunoprecipitat
Monoclonal antibody specific for capsid antigen of Epstein-Barr virus
✍ Scribed by K. Takada; S. Fujiwara; S. Yano; T. Osato
- Publisher
- Springer-Verlag
- Year
- 1983
- Tongue
- English
- Weight
- 704 KB
- Volume
- 171
- Category
- Article
- ISSN
- 0300-8584
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The feasibility of using elevated Epstein-Barr virus (EBV) specific-IgG antiviral capsid antigen (VCA) and IgA anti-VCA antibody levels as an aid in diagnosis of nasopharyngeal carcinoma (NPC) was analyzed by determination of serum antibody titers to EBV in 54 NPC patients, 114 healthy blood donors,
## Abstract Rabbits were immunized with nuclear or cyto‐plasmic extracts of the Epstein‐Barr virus (EBV)‐producing marmoset cell line B95‐8. Following extensive absorption with human EBV‐negative cells (Hep‐2, Ramos and BJAB), sera were obtained that no longer reacted with cellular or serum protein
## Abstract Antibody titers to Epstein‐Barr virus (EBV)‐specific antigens of 19 patients with hairy‐cell leukemia (HCL) were markedly elevated. All patients showed high titers of IgG anti‐viral capsid antigen (VCA) reactivity equal to or greater than 320 (reciprocal titer). The anti‐VCA reciprocal